Leaving previously implanted central venous catheters (ports) in place does not increase morbidity in patients undergoing autologous peripheral stem cell transplantation
Related Experiment Video
Updated: Aug 17, 2026

A Protocol to Set Up Needle-Free Connector with Positive Displacement on Central Venous Catheter in Intensive Care Unit
Published on: July 13, 2019
1Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA. MiceliMarisaH@uams.edu
Insights
Leaving implantable catheters (IC) in place during autologous peripheral stem cell transplantation (APSCT) did not increase patient morbidity. This study found no significant rise in fever, infection, or mortality, suggesting ICs can remain safely.
Area of Science:
- Hematology
- Oncology
- Infectious Diseases
Background:
- Implantable catheters (IC) are frequently used in patients undergoing autologous peripheral stem cell transplantation (APSCT).
- Concerns exist regarding potential increased morbidity associated with leaving pre-inserted, non-colonized, or infected ICs in place during APSCT.
Purpose of the Study:
- To evaluate whether leaving a pre-inserted implantable catheter (IC) in place during autologous peripheral stem cell transplantation (APSCT) is associated with increased patient morbidity.
- To compare outcomes between patients undergoing APSCT with an IC in place versus those without an IC.
Main Methods:
- Retrospective review of medical records for patients undergoing APSCT between March 1997 and January 2002.
- Matched case-control study comparing 43 patients with an IC in place (case group) to 43 patients without an IC (control group).
- Outcomes assessed included fever, bloodstream infection, vancomycin/amphotericin B use, death, length of stay, and readmissions.
Main Results:
- No significant differences were observed in rates of fever, bloodstream infection, death, length of stay, or readmissions between the IC and no-IC groups.
- The use of an IC was associated with increased utilization of antibacterial and antifungal agents.
- 20 out of 43 patients in the case group had an IC in place.
Conclusions:
- Leaving a previously inserted, non-colonized or infected implantable catheter (IC) in place does not significantly increase morbidity in patients undergoing autologous peripheral stem cell transplantation (APSCT).
- While IC use did not elevate major adverse events, it was linked to higher antimicrobial usage.
Abstract:
We sought to assess if leaving in place a previously inserted noncolonized or infected implantable catheter (IC) is associated with an increase in morbidity in patients undergoing autologous peripheral stem cell transplantation (APSCT). Medical records from all patients between March 1997 and January 2002 undergoing APSCT with an IC in place were reviewed. Case group (IC in place) was compared with a control group (no IC) from 6 days prior to 60 days after APSCT. In all, 43 cases were matched with 43 controls by underlying disease, age and sex. In both groups, duration of neutropenia and use of antimicrobial prophylaxis were comparable. Underlying malignancies were lymphoma (22/24), multiple myeloma (14/12), leukemia (3/3), and others (7/7) in case and control groups. Cases and controls had comparable rates of risk for fever, bloodstream infection, use of vancomycin and amphotericin B, and death, as well as comparable lengths of stay and readmissions. ICs were used in 20 of 43 patients. Using the IC did not significantly increase the risk of fever, bloodstream infection, length of stay, and/or readmissions after APSCT but was associated with increased use of antibacterial and antifungal agents. Leaving in place a previously inserted, noncolonized or infected IC did not increase morbidity in patients undergoing APSCT.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Peripheral Artery Disease V: Postoperative Nursing Management
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Hemodialysis I: Introduction
